control
Showing 26 - 50 of 220
Sepsis, Vitamin C, Intensive Care Unit Trial in Sherbrooke (Vitamin C, Control)
Completed
- Sepsis
- +5 more
- Vitamin C
- Control
-
Sherbrooke, Quebec, CanadaResearch Center of the CHUS
Mar 23, 2022
Cytoflavin in Combination With Reperfusion in Stroke Patients
Not yet recruiting
- Acute Stroke
- Cytoflavin (succinic acid + inosine + nicotinamide + riboflavin)
- Control
- (no location specified)
Apr 4, 2022
Breast Cancer, Liver Metastases Trial in Umeå (Surgical intervention, Control)
Recruiting
- Breast Cancer
- Liver Metastases
- Surgical intervention
- Control
-
Umeå, SwedenUmeå University Hospital
May 24, 2022
Chronic Kidney Disease, Cardiac Disease Trial in Jakarta (Furosemide, Control)
Completed
- Chronic Kidney Disease
- Cardiac Disease
- Furosemide
- Control
-
Jakarta, IndonesiaNational Cardiovascular Center Harapan Kita Jakarta
Mar 8, 2022
Esophageal Stenosis, Anastomotic Stenosis Trial in Philadelphia (Mitomycin C, Control)
Withdrawn
- Esophageal Stenosis
- Anastomotic Stenosis
- Mitomycin C
- Control
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Apr 1, 2022
Autosomal Dominant Polycystic Kidney Disease Trial in Australia (Metformin XR, Control)
Not yet recruiting
- Autosomal Dominant Polycystic Kidney Disease
- Metformin XR
- Control
-
Sydney, New South Wales, Australia
- +3 more
Nov 9, 2022
Knee Osteoarthritis Trial in Chicago (Vitamin D, Control)
Completed
- Knee Osteoarthritis
- Vitamin D
- Control
-
Chicago, IllinoisRush University medical Center
Mar 3, 2022
Cataract Trial in Saint Louis, Ladson, Fitzroy (Levofloxacin Ocular Implant, Control)
Not yet recruiting
- Cataract
- Levofloxacin Ocular Implant
- Control
-
Saint Louis, Missouri
- +2 more
Jun 28, 2022
Plaque Psoriasis Trial in New York (PH-10 (rose bengal disodium 0.001%), Control)
Terminated
- Plaque Psoriasis
- PH-10 (rose bengal disodium 0.001%)
- Control
-
New York, New YorkMount Sinai School of Medicine
Dec 1, 2021
Depressive Disorder Trial in New York (Carbidopa/levodopa, Placebo, Exercise training)
Suspended
- Depressive Disorder
- Carbidopa/levodopa
- +3 more
-
New York, New YorkNew York State Psychiatric Institute
Jan 26, 2022
Spasmodic Dysphonia Trial in Phoenix (drug, device, other)
Recruiting
- Spasmodic Dysphonia
- Lidocaine
- +2 more
-
Phoenix, ArizonaMayo Clinic in Arizona
Sep 29, 2021
Respiratory Distress Syndrome, Adult Trial in Tuebingen (Iloprost, control)
Completed
- Respiratory Distress Syndrome, Adult
- Iloprost
- control
-
Tuebingen, GermanyUniversity Hospital Tuebingen
Dec 8, 2021
Anorexia Nervosa/Bulimia, Anorexia in Adolescence, Anorexia Nervosa, Atypical Trial in Hershey (Naltrexone Hydrochloride,
Enrolling by invitation
- Anorexia Nervosa/Bulimia
- +8 more
- Naltrexone Hydrochloride
- Control
-
Hershey, PennsylvaniaPenn State Milton S. Hershey Medical Center
Aug 25, 2022
Heart Failure Trial in Murcia (Complete removal of pharmacological treatment, Control)
Recruiting
- Heart Failure
- Complete removal of pharmacological treatment
- Control
-
Murcia, SpainHospital Clínico Universitario Virgen de la Arrixaca
Dec 9, 2021
AML, MDS, ALL, Adult Trial in Hackensack, New York (SOC + TSC-100, SOC + TSC-101, Control)
Recruiting
- AML
- +2 more
- SOC + TSC-100
- +2 more
-
Hackensack, New Jersey
- +1 more
Aug 11, 2022
Vitamin C, COVID-19, Hospitalized Patients Trial in Sherbrooke (Vitamin C, Control)
Recruiting
- Vitamin C
- +2 more
- Vitamin C
- Control
-
Sherbrooke, Quebec, Canada
- +1 more
Jan 20, 2022
Postoperative Pain Trial in Exeter (TAP Block, Control)
Completed
- Postoperative Pain
- TAP Block
- Control
-
Exeter, United KingdomRoyal Devon and Exeter NHS Foundation Trust
Apr 27, 2021
Acute Kidney Injury, Shock Trial in São Paulo (Methylene Blue, Control)
Not yet recruiting
- Acute Kidney Injury
- Shock
- Methylene Blue
- Control
-
São Paulo, BrazilFederal University of São Paulo
Oct 24, 2021
Catheter Related Complication Trial in Ankara (Tramadol, Dexmedetomidine, control)
Completed
- Catheter Related Complication
- Tramadol
- +2 more
-
Ankara, TurkeyDiskapi Training and Research Hospital
Nov 8, 2021
Bullous Pemphigoid Trial in Nice, Marseille, Montpellier (Avdoralimab (IPH5401), Control)
Recruiting
- Bullous Pemphigoid
- Avdoralimab (IPH5401)
- Control
-
Nice, Alpes-Maritimes, France
- +3 more
Feb 18, 2022
Type 2 Diabetes, Peripheral Arterial Disease Trial in Napoli (Liraglutide, Control)
Recruiting
- Type 2 Diabetes
- Peripheral Arterial Disease
- Liraglutide
- Control
-
Napoli, ItalyUnit of Endocrinology and Metabolic Diseases and Unit of Diabete
Jun 9, 2021
Chondromalacia Patellae Trial in Ankara (radiofrequency, control, 2% lidocaine)
Recruiting
- Chondromalacia Patellae
- radiofrequency
- +2 more
-
Ankara, TurkeyGaziler Physical Medicine and Rehabilitation Education and Resea
Oct 26, 2021
Brain Metastases, Radiotherapy Side Effect, Cognitive Impairment Trial in Guangzhou (Monosialotetrahexosyl ganglioside (GM1),
Recruiting
- Brain Metastases
- +4 more
- Monosialotetrahexosyl ganglioside (GM1)
- Control
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Nov 3, 2021